Delivering Optimized, Outbound-Focused Contact Center Solutions for Modern Businesses LAUDERDALE LAKES, Fla. , Dec. 27, 2024 /PRNewswire/ -- outboundIQ www.outboundiq.com proudly announces its accreditation as a Five9 Certified Implementation Partner (CIP), a distinction that reflects its deep expertise in optimizing and streamlining outbound-focused contact center operations. With a team of seasoned Five9 veterans, expert programmers, and industry thought leaders, outboundIQ is uniquely equipped to help businesses of all sizes unlock the full potential of Five9's Virtual Contact Center platform. Optimized Solutions for Complex Contact Center Needs outboundIQ specializes in providing expedited, outbound-focused contact center implementations, integrating advanced features such as inbound and outbound Voice, SMS, Chat, Email, Salesforce Integration, and other third-party app integrations. Clients can also leverage ongoing optimization engagements and monthly retainers for strategic consulting designed to support long-term, outreach-focused success. "Who better to handle your domain configuration than the experts that understand the outbound contact center world. To be an outbound expert, you must know 3 things; how to configure the domain front end, how the architecture interprets that design, and how carriers respond to your dialing behavior as a result of the build. outboundIQ has the advantage of deeply understanding all 3 things. Our experts are seasoned professionals that will guide toward the best build for your business. You tell us about your business, your needs and your processes, and we will build you a domain fit for purpose. outboundIQ offers best in class Domain Optimization, Implementation and Consulting for customers of all sizes and complexity. Due to our methodology and proprietary automations, we are able to bring our customers' projects to life within accelerated timeframes." - Jessica Clay , VP Support and Services "We launched our business in June and were fortunate to connect with the incredible team at outboundIQ early on. Navigating the world of outbound calling and building efficient prospecting systems isn't easy, but the entire team at outboundIQ brought our vision to life seamlessly. They implemented our ideas quickly and executed them flawlessly. Since partnering with them, our contact rates have significantly improved, our conversions have increased, and our overall business is thriving. We're deeply grateful for this collaboration and look forward to continuing our work together on future endeavors!" - Tim, Lit Financial "I genuinely don't know enough ways to thank the entire outboundIQ team. I inherited a domain riddled with mistakes, tangled beyond belief, and I had essentially planned to scrap the whole thing and start over. That's when this team, led by Jessica Clay's brilliance, took over to understand exactly what I wanted to create and completely revitalized my domain. We are all beyond thankful as they continue to consult for us to this day and I see no reason to stop. Thank you, Jessica, Jason, Rudy, Bruno, Sandy and everyone who gets the pleasure of working with these domain geniuses!" - Michael, Lifetime Home Remodeling A Holistic Approach to Outbound Excellence Creating a competitive, consumer-focused outreach program requires more than just advanced technology. As outboundIQ explains, a thriving contact center functions like a high-performing racing team: outboundIQ's professional services team brings these critical elements together, ensuring clients achieve best-in-class outbound operations that prioritize consumer experience while maintaining a competitive edge. A Call to Collaboration With its new CIP certification, outboundIQ invites businesses to explore select partnership opportunities and projects to reimagine their contact center operations. Whether through expedited implementations or ongoing strategic consulting, outboundIQ is committed to driving measurable results for its clients. About outboundIQ outboundIQ delivers optimized, outbound-focused contact center implementations, combining years of Five9 expertise with cutting-edge strategies to help businesses achieve exceptional outreach outcomes. As a Five9 Certified Implementation Partner, outboundIQ provides tailored solutions to meet the unique needs of modern organizations. About Five9 Five9 is a digital enterprise's leading cloud contact center and software provider. The Five9 Intelligent CX Platform is reliable, secure, compliant, and scalable, designed to create exceptional personalized customer experiences. www.five9.com Media contact: Sandy Tafur Phone: 404-660-5314 mail: sandy@outboundiq.com View original content to download multimedia: https://www.prnewswire.com/news-releases/outboundiq-achieves-certified-implementation-partner-cip-status-with-five9-302339797.html SOURCE outboundIQLIBERTY LAKE, Wash., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, marks a significant milestone with the 50th deployment of its Temetra ® solution in Australia, which is being deployed by Aqwest, the provider of drinking water to the City of Bunbury and its surrounding areas in Western Australia. With Itron’s cloud-based multi-vendor meter data collection and management solution, Aqwest will be able to manage its existing mechanical meters while enhancing and optimizing operations. Aqwest selected Temetra, Itron’s innovative cloud-based solution, to simplify meter data collection by utilizing a solution capable of incorporating multi-vendor meter reads. With the adoption of Temetra, Aqwest can now upgrade to digital meters at a pace best suited for its operations and seamlessly collect meter readings from existing mechanical meters and future smart meters through a single data collection and management platform. This multi-vendor capability allows Aqwest to gain comprehensive insights into consumption patterns through one unified platform. Utilizing Aqwest’s existing communication protocols and meter vendors, Temetra will collect, record and upload meter data using the handheld mobile Android devices currently in use by the utility. Temetra provides valuable insights by analyzing both current reads and historical data, enabling Aqwest to address customer billing questions and detect potential water leaks. This 50th customer milestone reinforces Itron’s commitment to addressing water scarcity in Australia and ensuring that communities are better equipped to manage water operations. The Temetra solution enables utilities to address critical water management tasks more efficiently. These capabilities are key to helping utilities anticipate and address potential water challenges before they turn into a crisis, such as losing water within the distribution system. “Aqwest is committed to providing sustainable, high-quality drinking water to the Bunbury Region. As the effects of climate change continue to impact on local water security, having an efficient water management system in place is crucial,” said Gary Hallsworth, chief executive officer at Aqwest. “We are delighted to be working with Itron to upgrade our water metering infrastructure to improve our customer consumption data and billing capabilities.” “Australia is no stranger to water shortages due to its dry climate, recurring droughts and the challenges caused by climate disruption, making water management a complex issue. On top of these challenges, population growth is increasing the demand on existing water infrastructure, much of which is aging and prone to inefficiencies,” said Don Reeves, senior vice president of Outcomes at Itron. “We are excited to celebrate this significant milestone. Working together with Australian utilities, we strive to deploy efficient solutions to address these challenges and to ensure that both remote and urban communities are equipped to tackle water management. With Temetra, utilities across the country are another step closer to water security.” Temetra is a globally adopted, cloud-based, multi-vendor, multi-commodity, meter data management solution. Temetra supports a variety of meter manufacturers and communications protocols enabling a smooth migration from automated meter reading to advanced meter reading. Temetra’s open ecosystem solution enables interoperability at all levels and supports multiple data collection technologies concurrently, providing utilities a smooth migration path from manual to smart metering. Storing meter read data from a variety of sources in one location, combined with other innovations like map-based routing, enhances operational efficiency. Temetra has demonstrated scalability, accommodating thousands of customers ranging in size from several hundred meters to several million. About Itron Itron is a proven global leader in energy, water, smart city, IIoT and intelligent infrastructure services. For utilities, cities and society, we build innovative systems, create new efficiencies, connect communities, encourage conservation and increase resourcefulness. By safeguarding our invaluable natural resources today and tomorrow, we improve the quality of life for people around the world. Join us: www.itron.com . Itron®, the Itron Logo and Temetra are registered trademarks of Itron, Inc in the United States and other countries and jurisdictions. All third-party trademarks are property of their respective owners and any usage herein does not suggest or imply any relationship between Itron and the third party unless expressly stated. For additional information, contact: Itron, Inc. Sharon Chong Field Marketing Manager, Asia Pacific Office: +65 69837687 sharon.chong@itron.com Paul Vincent Vice President, Investor Relations 512-560-1172 Investors@itron.com Itron, Inc.
Miami of Ohio and Colorado State will try to overcome notable transfer-portal defections during Saturday's Arizona Bowl at Tucson, Ariz. Miami (8-5) enters the game without its top two wide receivers Javon Tracy and Reggie Virgil after the duo elected to play elsewhere. Tracy, a redshirt sophomore who caught 57 passes for 818 yards with seven touchdowns, is moving on to Minnesota. Virgil, a junior who tallied 816 yards on 41 receptions with nine touchdowns, is bound for Texas Tech. "It's kind of insane, to be honest," Miami coach Chuck Martin said. "We'll lose some real good kids in the portal, but we'll also gain some good ones. It's just crazy. "In some ways, it stinks, but in some ways, it's fun, too. We're looking at a lot of some good ones." Miami has also lost two cornerbacks, including sophomore Raion Strader to Auburn. Strader had 53 tackles with two interceptions and a team-best 17 passes broken up. Will Jados, a redshirt junior offensive tackle who started 38 games for Miami, is transferring to Texas Tech. Colorado State (8-4) also lost its two top receivers in the portal. Sophomore Caleb Goodie committed to Cincinnati and sophomore Jamari Person remains undecided. Goodie caught 21 passes for 436 yards with four touchdowns, and Person had 36 receptions for 386 yards and a touchdown. Another sophomore, linebacker Buom Jock, also is in the transfer portal after he led the Rams with 100 tackles. "They lost a couple receivers in the portal, just like us, so they've adjusted, just like most teams in the bowl season have adjusted to the team that they have available," Colorado State coach Jay Norvell said. Redshirt sophomore Armani Winfield, who had 37 catches for 338 yards and two touchdowns, is the top available receiver for the Rams. Miami's leading receiver entering the game is fifth-year senior Cade McDonald (49 catches for 606 yards and three touchdowns). Miami won seven straight games before losing to Ohio in the MAC championship game behind sixth-year quarterback Brett Gabbert, who has completed 57.6 percent of his passes (204 of 354) for 2,737 yards and 21 touchdowns. Gabbert has been prone to throw interceptions, with 11, including one against Ohio in the conference title game. He did not throw an interception in a 30-20 victory over Ohio earlier this season. Keyon Mozee is Miami's featured running back with 1,073 yards on 170 carries with four touchdowns. Matt Salopek, a sixth-year linebacker, leads Miami with 113 tackles. He is the first player in program history with four 100-tackle seasons. Colorado State won six of its last seven games -- committing only seven turnovers in that span. Senior running back Avery Morrow has 956 yards on 166 attempts with nine touchdowns. Brayden Fowler-Nicolosi, a redshirt sophomore, has thrown for 2,475 yards while completing 207 of 335 attempts (61.8 percent) with 13 touchdowns and seven interceptions. Chase Wilson, a fifth-year senior linebacker, has 91 tackles this season, three for loss. --Field Level MediaEquity market sustains bullish run, gains N504bn
JannHuizenga The stock market is set to end the year with one of the strongest annual performances since the turn of the century, save any major sell-offs in the second half of December. The year-to-date performance of the S&P 500 Index (SP500, SPX) sits Analyst’s Disclosure: I/we have a beneficial long position in the shares of SPY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Itron Marks Significant Milestone of 50th Temetra Deployment in Australia
DrBalcony App Redefines Balcony Inspections with Unparalleled Efficiency
METAIRIE, La. (AP) — If Saints interim coach Darren Rizzi has any definite ideas about who'll play quarterback for New Orleans against Washington on Sunday, he's not ready to share that information. Rizzi maintained on Wednesday that there's still a chance that Derek Carr could clear the concussion protocol and function well enough with his injured, non-throwing left hand to return against the Commanders. Meanwhile, reserve QBs Jake Haener and Spencer Rattler split first-team snaps during Wednesday's practice, which Carr missed, Rizzi said. “We're not going to name a starter right now,” said Rizzi, who also made a point of noting that Carr would not be placed on the club's injured reserve list and would not need surgery. “We're going to see how that progression plays out, first with Derek and then obviously with Jake and Spencer.” Carr, whose latest injury occurred when he tried to dive for a first down during Sunday's 14-11 victory over the New York Giants , has already missed three starts this season because of a separate, oblique injury. New Orleans lost all three of those games, with Rattler, a rookie, starting and Haener, a second-year pro, serving as the backup. In his three starts, Rattler completed 59 of 99 passes (59.6%) for 571 yards, one TD and two interceptions. Haener has gotten sporadic work this season in relief of both Carr and Rattler, completing 14 of 29 passes (48.3%) for 177 yards and one TD without an interception. Rizzi said he finds the 6-foot-1 Haener and 6-foot Rattler “very similar in a lot of ways," adding that whichever of those two might play “doesn't change a whole bunch" in terms of game-planning. “They're both similar-size guys. Their athletic ability is very similar,” Rizzi said. “They're similar-style quarterbacks. We're not dealing with opposites on the spectrum.” The Saints also signed another QB this week — Ben DiNucci — to help take scout team snaps at practice, now that Rattler and Haener are not as available to do that while competing to possibly start if Carr is indeed unable to play. The Saints (5-8) have won three of four games since Rizzi took over following the firing of coach Dennis Allen. That allowed New Orleans to remain alive in the NFC South Division, currently led by Tampa Bay (7-6). Rizzi said Carr has not had any setbacks this week in terms of progressing through the NFL's concussion protocol. “By the end of the week, if's he's not able to get any reps in any form or fashion, then obviously we'll go with one of the other guys,” Rizzi said. NOTES: RB Alvin Kamara did not practice on Wednesday because of an illness. ... WR Chris Olave, who is out indefinitely because of concussions this season, has returned to meetings at Saints headquarters. He as not, however, made plans to return to practice yet because he still plans to meet first with neurological specialists to try to assess the risks of returning to action during what's left of this season. Rizzi said the possibility of Olave playing again this season remains “on the table” for now. AP NFL: https://apnews.com/hub/NFLSpecial election dates set for vacant state Senate seat in Orange and Los Angeles countiesMAPUTO, Mozambique (AP) — Violence that engulfed Mozambique after the country’s highest court confirmed ruling Frelimo party presidential candidate Daniel Chapo as the winner of disputed Oct. 9 elections killed at least 21 people, including two police officers, authorities said Tuesday. Mozambique Interior Minister Pascoal Ronda told a news conference in Maputo late Tuesday that a wave of violence and looting was sparked by the court’s announcement a day earlier. He said it was led by mostly youthful supporters of losing candidate Venancio Mondlane, who received 24% of the vote, second to Chapo, who got 65%. “From the preliminary survey, in the last 24 hours, 236 acts of violence were recorded throughout the national territory that resulted in 21 deaths, of which two members of the Police of the Republic of Mozambique also died,” Ronda said. He said 13 civilians and 12 police were injured. Ronda said 25 vehicles were set on fire, including two police vehicles. He added that 11 police subunits and a penitentiary were attacked and vandalized and 86 inmates were freed. Tensions were high in the country ahead of the The Constitutional Council ruling on Monday and violent protests started immediately after the announcement was made. Footage circulating on various social media platforms showed protesters burning and looting shops in the capital Maputo and the city of Beira, where some city officials were reported to have fled the city. Mondlane has called for a “shutdown” starting Friday but violence in the country has already escalated and the situation remained tense in the capital on Tuesday night following a day of violence and looting by protesters. The country of 34 million people has been on edge since the Oct. 9 general elections . Mondlane’s supporters, mostly hundreds of thousands of young people, have since taken to the streets, and have been met by gunfire from security forces. This brings to more than 150 the number of people who have died from post-election violence since the initial results were announced by the country’s electoral body.
DrBalcony App Redefines Balcony Inspections with Unparalleled EfficiencyCORNELIUS, N.C. and NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Modus Corp. ("Alpha Modus" or the “Company”), a technology company with a core focus on artificial intelligence in retail, and Insight Acquisition Corp., a special purpose acquisition company (“Insight” NASDAQ: INAQ) plan to close their business combination today. Alpha Modus expects to begin trading on the Nasdaq Global Market under the ticker symbols “AMOD” (its common stock) and “AMODW” (its warrants) on Monday, December 16, 2024. About Alpha Modus Alpha Modus engages in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision. The company was founded in 2014 and is headquartered in Cornelius, North Carolina. For additional information, please visit alphamodus.com . About Insight Acquisition Corp. Prior to the closing, Insight Acquisition Corp. (NASDAQ: INAQ) is a special purpose acquisition company formed solely to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Insight Acquisition Corp. is sponsored by Insight Acquisition Sponsor LLC. For additional information, please visit insightacqcorp.com . Forward-Looking Statements This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Insight's and Alpha Modus' actual results may differ from their expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements, but are not the exclusive means of identifying these statements. These forward-looking statements include, without limitation, Insight's and Alpha Modus' expectations with respect to future performance and anticipated financial impacts of the Business Combination. Insight and Alpha Modus caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Insight and Alpha Modus do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions, or circumstances on which any such statement is based. Contacts: Alpha Modus Shannon Devine MZ Group +1(203) 741-8841 shannon.devine@mzgroup.usThe Friday college basketball slate is stacked and Underdog Fantasy promo code BETFPB guarantees a 50% deposit bonus up to $1,000 to all new customers. Wager on college basketball props for all available games including: Simply register using our Underdog Fantasy promo code BETFPB , then make an initial deposit. That investment will be matched 50% of the way up to $1,000. If you seek an alternative to sportsbooks or you aren't in a legal betting state, Underdog is for you. It's widely available and offers the chance to combine multiple Higher or Lower (Over/Under) picks into a single entry, just like a parlay. Underdog also has live props throughout the game. Registering by clicking one of our links or entering Underdog Fantasy promo code BETFPB while signing up means qualifying for a bonus up to $1,000 once you register and make an initial deposit, which Underdog matches 50% of the way. Note: This Underdog Fantasy bonus is available in AL, AK, AZ, AR, CA, CO, DC, FL, GA, IL, IN, KS, KY, MA, MN, MS, NE, NM, NY, NC, ND, OK, OR, RI, SC, SD, TX, UT, VT, VA, WI, WY & All Canadian Provinces except ON. All new customers can earn up to $1,000 in bonuses to play with at Underdog. Follow the steps listed below to claim the promo: The bonus will land in your account within 72 hours and must be used within 60 days. This is a great way to test out the platform. Underdog Fantasy is available in over 30 states including many without legal sports betting. If you live in an eligible state, you can take full advantage of the platform and sign up to play fun daily fantasy contests. In the run up to Thanksgiving, the college basketball slate is packed with holiday tournaments and wall-to-wall action. As a result, there are several appetizing games every day and perhaps none more so than No. 17 Arizona vs. No. 12 Duke (10:30 p.m. ET on ESPN2). The schedule includes: Duke is 3-1 but is playing its first game away from home while Arizona is 2-0 and remains in the friendly confines of the McKale Center for this one. Arizona is a slim 1.5-point favorite with the total at 161 points at DraftKings. Claim $1,000 deposit bonus from Underdog Fantasy Each game houses plenty of college football player props and for each one, bettors must choose Higher or Lower on the total set by Underdog. This includes points, rebounds, assists, stat combinations and more. From there, make between 2 and 8 selections to put into an entry, with the payouts increasing with each added selection. For entries of three selections or more, a 'flex' option is available that will pay out a portion of winnings even if one of your selections falls short. Please note that college football props may be limited to select states, so check your local listings on the Underdog app. There are a variety of contests that users can enter on the Underdog Fantasy platform. These are different game styles that let users test their knowledge in different ways. After you take advantage of the Underdog Fantasy promo bonus using the code BETFPB , you will see all of these different game types offered to you. There are two main contests that are used for contests at Underdog Fantasy. They are the Pick ‘Em contest and the Draft contest. They work as follows. You must be over 21 to play. Gambling Problem? Call 1-800-522-4700. 1-800 GAMBLER. Brian Sausa is a New York-based content creator for Catena Media with an extensive betting history and several years of iGaming industry experience. A journalism graduate with a ranging sports background, Brian’s previous employment includes the flagship sites for multiple professional leagues including the MLB and NHL. Get local news delivered to your inbox!
CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full Year 2024 Business Highlights and Subsequent Developments Achieved U.S. Food and Drug Administration (FDA) approval of LYMPHIRTM (denileukin diftitox-cxdl), an immunotherapy for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma (CTCL); Began trading on the Nasdaq exchange under the ticker symbol CTOR on August 13, 2024 , following completion of the merger of Citius Pharma's oncology subsidiary with TenX Keane to form Citius Oncology, Inc., a standalone publicly traded company; Advanced manufacturing, marketing and sales activities in preparation for commercial launch of LYMPHIR in the first half of 2025; key activities included: Manufactured initial inventory for launch and finalized supply chain agreements, Initiated recruitment of targeted field force with contract sales organization, Launched a marketing awareness campaign and engaged with all leading CTCL prescribers, Applied for a unique J-code within the Healthcare Common Procedure Coding System (HCPCS) to facilitate accurate reimbursement, Secured inclusion of LYMPHIR in the National Comprehensive Cancer Network (NCCN) guidelines, critical to clinical decision-making in oncology and hematology, influencing treatment practices and payor reimbursement in the U.S., and Initiated development of the patient support center to help patients access LYMPHIR expeditiously; Supported two investigator-initiated trials to explore LYMPHIR's potential as an immuno-oncology combination therapy being conducted at the University of Pittsburgh Medical Center and the University of Minnesota ; and, Shared interim trial results with the clinical community at the Society for Immunotherapy of Cancer Conference (SITC) of University of Pittsburgh Medical Center's Phase I trial of LYMPHIR with checkpoint inhibitor pembrolizumab. The combination of these two immunomodulatory agents showed clinical benefit in relapsed or refractory gynecological neoplasms, resulting in: 27% objective response rate and 33% clinical benefit rate with median progression free survival of 57 weeks (range: 30-96 weeks), and A manageable safety profile whereby the regimen was well-tolerated with reversible treatment emergent adverse events and no definitive immune-related adverse events greater than or equal to grade 3 documented. Financial Highlights R&D expenses were $4.9 million for the full year ended September 30, 2024 , compared to $4.2 million for the full year ended September 30, 2023 ; G&A expenses were $8.1 million for the full year ended September 30, 2024 , compared to $5.9 million for the full year ended September 30, 2023 ; Stock-based compensation expense was $7.5 million for the full year ended September 30, 2024 , compared to $2.0 million for the full year ended September 30, 2023 ; and, Net loss was $21.1 million , or ($0.31) per share for the full year ended September 30, 2024 compared to a net loss of $12.7 million , or ($0.19) per share for the full year ended September 30, 2023 . "Reflecting on 2024, Citius Oncology has achieved pivotal milestones that underscore our commitment to advancing cancer therapeutics," stated Leonard Mazur , Chairman and CEO of Citius Oncology. "The FDA's approval of LYMPHIR for the treatment of cutaneous T-cell lymphoma marks a significant advancement in providing new options for patients battling this challenging disease. It is the only targeted systemic therapy approved for CTCL patients since 2018 and the only therapy with a mechanism of action that targets the IL-2 receptor. Additionally, the successful merger forming Citius Oncology, now trading on Nasdaq under the ticker CTOR, strengthens our position in the oncology sector. We expect it to facilitate greater access to capital to fund LYMPHIR's launch and the Company's future growth. With a Phase I investigator-initiated clinical trial combining LYMPHIR with pembrolizumab demonstrating promising preliminary results, indicating potential for enhanced treatment efficacy in recurrent solid tumors, and preliminary results expected from a second investigator trial with CAR-T therapies in 2025, we remain excited about the potential of LYMPHIR as a combination immunotherapy." "These accomplishments reflect the dedication of our team and the trust of our investors. As we look ahead, we remain steadfast in our mission to develop innovative therapies that improve the lives of cancer patients worldwide," added Mazur. FULL YEAR 2024 FINANCIAL RESULTS: Research and Development (R&D) Expenses R&D expenses were $4.9 million for the full year ended September 30, 2024 , compared to $4.2 million for the full year ended September 30, 2023 . The increase reflects development activities completed for the resubmission of the Biologics License Application of LYMPHIR in January 2024 , which were associated with the complete response letter remediation. General and Administrative (G&A) Expenses G&A expenses were $8.1 million for the full year ended September 30, 2024 , compared to $5.9 million for the full year ended September 30, 2023 . The increase was primarily due to costs associated with pre-commercial and commercial launch activities of LYMPHIR including market research, marketing, distribution and drug product reimbursement from health plans and payers. Stock-based Compensation Expense For the full year ended September 30, 2024 , stock-based compensation expense was $7.5 million as compared to $2.0 million for the prior year. The primary reason for the $5.5 million increase was due to the amounts being realized over 12 months in the year ended September 30, 2024 , as compared to three months post-plan adoption in the year ended September 30, 2023 . Net loss Net loss was $21.1 million , or ($0.31) per share for the year ended September 30, 2024 , compared to a net loss of $12.7 million , or ($0.19) per share for the year ended September 30, 2023 . The $8.5 million increase in net loss was primarily due to the increase in our operating expenses. About Citius Oncology, Inc. Citius Oncology specialty is a biopharmaceutical company focused on developing and commercializing novel targeted oncology therapies. In August 2024 , its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estimates the initial market for LYMPHIR currently exceeds $400 million , is growing, and is underserved by existing therapies. Robust intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology use as a combination therapy with checkpoint inhibitors would further support Citius Oncology's competitive positioning. Citius Oncology is a publicly traded subsidiary of Citius Pharmaceuticals. For more information, please visit www.citiusonc.com Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Oncology. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Oncology are: our ability to raise additional money to fund our operations for at least the next 12 months as a going concern; our ability to commercialize LYMPHIR and any of our other product candidates that may be approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; risks related to research using our assets but conducted by third parties; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our Securities and Exchange Commission ("SEC") filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our SEC filings which are available on the SEC's website at www.sec.gov , including in Citius Oncology's Annual Report on Form 10-K for the year ended September 30, 2024 , filed with the SEC on December 27, 2024 , as updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Investor Contact: Ilanit Allen ir@citiuspharma.com 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg Greg@STiR-communications.com -- Financial Tables Follow – CITIUS ONCOLOGY, INC. CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, 2024 AND 2023 2024 2023 Current Assets: Cash and cash equivalents $ 112 $ — Inventory 8,268,766 — Prepaid expenses 2,700,000 7,734,895 Total Current Assets 10,968,878 7,734,895 Other Assets: In-process research and development 73,400,000 40,000,000 Total Other Assets 73,400,000 40,000,000 Total Assets $ 84,368,878 $ 47,734,895 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 3,711,622 $ 1,289,045 License payable 28,400,000 — Accrued expenses — 259,071 Due to related party 588,806 19,499,119 Total Current Liabilities 32,700,429 21,047,235 Deferred tax liability 1,728,000 1,152,000 Note payable to related party 3,800,111 — Total Liabilities 38,228,540 22,199,235 Stockholders' Equity: Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding — — Common stock - $0.0001 par value; 100,000,000; 71,552,402 and 67,500,000 shares issued and outstanding at September 30, 2024 and 2023, respectively 7,155 6,750 Additional paid-in capital 85,411,771 43,658,750 Accumulated deficit (39,278,587) (18,129,840) Total Stockholders' Equity 46,140,339 25,535,660 Total Liabilities and Stockholders' Equity $ 84,368,878 $ 47,734,895 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Revenues $ — $ — Operating Expenses: Research and development 4,925,001 4,240,451 General and administrative 8,148,929 5,915,290 Stock-based compensation – general and administrative 7,498,817 1,965,500 Total Operating Expenses 20,572,747 12,121,241 Loss before Income Taxes (20,572,747) (12,121,241) Income tax expense 576,000 576,000 Net Loss $ (21,148,747) $ (12,697,241) Net Loss Per Share – Basic and Diluted $ (0.31) $ (0.19) Weighted Average Common Shares Outstanding – Basic and Diluted 68,053,607 67,500,000 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Cash Flows From Operating Activities: Net loss $ (21,148,747) $ (12,697,241) Adjustments to reconcile net loss to net cash provided by operating activities: Stock-based compensation expense 7,498,817 1,965,500 Deferred income tax expense 576,000 576,000 Changes in operating assets and liabilities: Inventory (2,133,871) - Prepaid expenses (1,100,000) (5,044,713) Accounts payable 2,422,577 1,196,734 Accrued expenses (259,071) (801,754) Due to related party 14,270,648 14,805,474 Net Cash Provided By Operating Activities 126,353 - Cash Flows From Investing Activities: License payment (5,000,000) - Net Cash Used In Investing Activities (5,000,000) - Cash Flows From Financing Activities: Cash contributed by parent 3,827,944 - Merger, net (2,754,296) - Proceeds from issuance of note payable to related party 3,800,111 - Net Cash Provided By Financing Activities 4,873,759 - Net Change in Cash and Cash Equivalents 112 - Cash and Cash Equivalents – Beginning of Year - - Cash and Cash Equivalents – End of Year $ 112 $ - Supplemental Disclosures of Cash Flow Information and Non-cash Activities: IPR&D Milestones included in License Payable $ 28,400,000 $LIBERTY LAKE, Wash., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, marks a significant milestone with the 50th deployment of its Temetra ® solution in Australia, which is being deployed by Aqwest, the provider of drinking water to the City of Bunbury and its surrounding areas in Western Australia. With Itron’s cloud-based multi-vendor meter data collection and management solution, Aqwest will be able to manage its existing mechanical meters while enhancing and optimizing operations. Aqwest selected Temetra, Itron’s innovative cloud-based solution, to simplify meter data collection by utilizing a solution capable of incorporating multi-vendor meter reads. With the adoption of Temetra, Aqwest can now upgrade to digital meters at a pace best suited for its operations and seamlessly collect meter readings from existing mechanical meters and future smart meters through a single data collection and management platform. This multi-vendor capability allows Aqwest to gain comprehensive insights into consumption patterns through one unified platform. Utilizing Aqwest’s existing communication protocols and meter vendors, Temetra will collect, record and upload meter data using the handheld mobile Android devices currently in use by the utility. Temetra provides valuable insights by analyzing both current reads and historical data, enabling Aqwest to address customer billing questions and detect potential water leaks. This 50 th customer milestone reinforces Itron’s commitment to addressing water scarcity in Australia and ensuring that communities are better equipped to manage water operations. The Temetra solution enables utilities to address critical water management tasks more efficiently. These capabilities are key to helping utilities anticipate and address potential water challenges before they turn into a crisis, such as losing water within the distribution system. “Aqwest is committed to providing sustainable, high-quality drinking water to the Bunbury Region. As the effects of climate change continue to impact on local water security, having an efficient water management system in place is crucial,” said Gary Hallsworth, chief executive officer at Aqwest . “We are delighted to be working with Itron to upgrade our water metering infrastructure to improve our customer consumption data and billing capabilities.” “Australia is no stranger to water shortages due to its dry climate, recurring droughts and the challenges caused by climate disruption, making water management a complex issue. On top of these challenges, population growth is increasing the demand on existing water infrastructure, much of which is aging and prone to inefficiencies,” said Don Reeves, senior vice president of Outcomes at Itron. “We are excited to celebrate this significant milestone. Working together with Australian utilities, we strive to deploy efficient solutions to address these challenges and to ensure that both remote and urban communities are equipped to tackle water management. With Temetra, utilities across the country are another step closer to water security.” Temetra is a globally adopted, cloud-based, multi-vendor, multi-commodity, meter data management solution. Temetra supports a variety of meter manufacturers and communications protocols enabling a smooth migration from automated meter reading to advanced meter reading. Temetra’s open ecosystem solution enables interoperability at all levels and supports multiple data collection technologies concurrently, providing utilities a smooth migration path from manual to smart metering. Storing meter read data from a variety of sources in one location, combined with other innovations like map-based routing, enhances operational efficiency. Temetra has demonstrated scalability, accommodating thousands of customers ranging in size from several hundred meters to several million. About Itron Itron is a proven global leader in energy, water, smart city, IIoT and intelligent infrastructure services. For utilities, cities and society, we build innovative systems, create new efficiencies, connect communities, encourage conservation and increase resourcefulness. By safeguarding our invaluable natural resources today and tomorrow, we improve the quality of life for people around the world. Join us: www.itron.com . Itron ® , the Itron Logo and Temetra are registered trademarks of Itron, Inc in the United States and other countries and jurisdictions. All third-party trademarks are property of their respective owners and any usage herein does not suggest or imply any relationship between Itron and the third party unless expressly stated. For additional information, contact: Itron, Inc. Sharon Chong Field Marketing Manager, Asia Pacific Office: +65 69837687 sharon.chong@itron.com Paul Vincent Vice President, Investor Relations 512-560-1172 Investors@itron.com Itron, Inc. LinkedIn: www.linkedin.com/company/itroninc X: https://twitter.com/ItronInc Newsroom: https://itron.com/newsroom Blog: https://itron.com/blogLouisiana hopes to slow TCU's Josh Hoover in New Mexico Bowl
Majority of Americans Approve of Trump's Second-Term Agenda
Musk says US is demanding he pay penalty over disclosures of his Twitter stock purchases DETROIT (AP) — Elon Musk says the Securities and Exchange Commission wants him to pay a penalty or face charges involving what he disclosed — or failed to disclose — about his purchases of Twitter stock before he bought the social media platform in 2022. In a letter, Musk’s lawyer Alex Spiro tells the outgoing SEC chairman, Gary Gensler, that the commission’s demand for a monetary payment is a “misguided scheme” that won’t intimidate Musk. The letter also alleges that the commission reopened an investigation this week into Neuralink, Musk’s computer-to-human brain interface company. The SEC has not released the letter. Nor would it comment on it or confirm whether it has issued such a demand to Musk. Senate begins final push to expand Social Security benefits for millions of people WASHINGTON (AP) — The Senate is pushing toward a vote on legislation that would provide full Social Security benefits to millions of people. Senate Majority Leader Chuck Schumer began the process on Thursday for a final vote on the bill, known as the Social Security Fairness Act. It would eliminate policies that currently limit Social Security payouts for roughly 2.8 million people. The legislation has passed the House. The bill would add more strain on the Social Security Trust funds, which are already estimated to be unable to pay out full benefits beginning in 2035. The measure would add an estimated $195 billion to federal deficits over 10 years, according to the Congressional Budget Office. Trump offers support for dockworkers union by saying ports shouldn't install more automated systems WASHINGTON (AP) — President-elect Donald Trump is offering his support for the dockworkers union before their contract expires next month at Eastern and Gulf Coast ports. He posted on social media Thursday that he met with union leaders and that any further “automation” of the ports would harm workers. He wrote that the “amount of money saved is nowhere near the distress, hurt, and harm it causes for American Workers.” The International Longshoremen’s Association has until Jan. 15 to negotiate a new contract with the U.S. Maritime Alliance, which represents ports and shipping companies. The Maritime Alliance says the technology will improve worker safety and strengthen our supply chains, among other things. IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power WASHINGTON (AP) — IRS leadership on Thursday announced that the agency has recovered $4.7 billion in back taxes and proceeds from a variety of crimes. The announcement comes under the backdrop of a promised reckoning from Republicans who will hold a majority over both chambers of the next Congress and have long called for rescinding the tens of billions of dollars in funding provided to the agency by Democrats. IRS Commissioner Danny Werfel said improvements made to the agency will help the incoming administration and new Republican majority congress achieve its goals of administering an extension of the 2017 Tax Cuts and Jobs Act. OpenAI's legal battle with Elon Musk reveals internal turmoil over avoiding AI 'dictatorship' A 7-year-old dispute between tech leaders Elon Musk and Sam Altman over who should run OpenAI and best avoid an artificial intelligence ‘dictatorship’ is now heading to a federal judge as Musk seeks to halt the ChatGPT maker’s ongoing conversion into a for-profit company. Musk, an early OpenAI investor and board member, sued the artificial intelligence company earlier this year. Musk has since escalated the dispute, adding new claims and asking for a court order that would stop OpenAI’s plans to convert itself into a for-profit business more fully. OpenAI is filing its response Friday. OpenAI's Altman will donate $1 million to Trump's inaugural fund LOS ANGELES (AP) — OpenAI CEO Sam Altman is planning to make a $1 million personal donation to President-Elect Donald Trump’s inauguration fund, joining a number of tech companies and executives who are working to improve their relationships the incoming administration. A spokesperson for OpenAI confirmed the move on Friday. The announcement comes one day after Meta, the parent company of Facebook and Instagram, said it donated $1 million to the same fund. Amazon also said it plans to donate $1 million. China signals it's prepared to double down on support for the economy as Trump tariffs loom BANGKOK (AP) — Chinese leaders met this week to plot economic policy for the coming year and sketched out plans to raise government spending and relax Beijing's monetary policy. Analysts said the broad-brush plans from the annual Central Economic Work Conference were more of a recap of current policy than ambitious new initiatives at a time when the outlook is clouded by the President-elect Donald Trump's threats to sharply raise tariffs once he takes office. The ruling Communist Party did commit to raising China's deficit and to doing more to encourage consumer spending by bringing wage increases in line with the pace of economic growth. Here's a look at China's main priorities and their potential implications. Stock market today: Wall Street slips at the end of a bumpy week Stocks slipped as Wall Street closes out a rare bumpy week. The S&P 500 was up less than 0.1% in afternoon trading Friday and headed for a weekly loss. The benchmark index hit its latest in a string of records a week ago. The Dow Jones Industrial Average fell 58 points. The Nasdaq composite was up 0.1%. Broadcom surged after the semiconductor company beat Wall Street’s profit targets and gave a glowing forecast, highlighting its artificial intelligence products. Treasury yields edged higher in the bond market. European markets were mostly lower and Asian markets mostly fell. Next Week: Retail sales, Fed policy update, existing home sales The Commerce Department releases its monthly snapshot of U.S. retail sales Tuesday. Federal Reserve officials wrap up a two-day meeting and issue an interest rate policy update Wednesday. The National Association of Realtors issues its latest update on U.S. home sales Thursday. African Union chairperson candidates advocate for permanent UN Security Council seats NAIROBI, Kenya (AP) — Three African leaders seeking to head the African Union have detailed their plans for regional security amid conflicts and political coups while strongly advocating for inter-Africa trade. The race for chairperson debate was held Friday in Ethiopian capital Addis Ababa. Kenya’s Raila Odinga, Djibouti’s Mahamoud Ali Youssouf and Madagascar’s Richard Randriamandrato are seeking to be elected as chairperson for the 55-member state African Union. They had a two-hour debate Friday in which they all advocated for two permanent seats for African countries at the U.N. Security Council to effectively represent the continent with the youngest population. The three are seeking to convince most African countries before the February election to succeed the African Union Chairperson Moussa Faki.One day, when actor and comedian Rosie O'Donnell was in her 50s, her body ached and her arms felt sore, but she pushed through the pain, not realizing she was having a massive heart attack. She had surgery to put in a stent that saved her life. Shortly after her 2012 heart attack, O'Donnell shared her experience on her blog. During her 2015 television standup special, she spoke about how the experience changed her life. The segment included a heart attack acronym the comedian coined: HEPPP (hot, exhausted, pain, pale, puke). O'Donnell's candidness about her heart attack helped spread awareness about how it can present differently in women. She's one of countless celebrities over the years who have opened up about their health conditions, including breast cancer, HIV, depression, heart disease and stroke. When celebrities reveal and discuss their health issues, the impact can be far-reaching. It not only helps to educate the public, but it also can reduce stigma and inspire others. People are also reading... Spreading kindness one butterfly at a time At the courthouse, Dec. 7, 2024 Camper total loss after fire north of Beatrice BPS receives a "good" classification Hubbell native, Gage County Fair performer hosting Christmas concert Holiday lights travel through downtown Beatrice for annual parade P.E.O. sponsors Holiday Tour of Homes Early names to know as Nebraska begins early shopping in the open transfer market Hit show ‘Yellowstone’ doesn’t just portray ranching in Montana. It has changed it. Amie Just: This recruiting class marks the beginning of a new era — one without walk-ons Orangemen wrestlers get their season started Now streaming and on DVD: 'Speak No Evil' scares the trip out of you Amie Just: A letter to Nebraska volleyball seniors ahead of their final match at Devaney At the courthouse, Nov. 30, 2024 "Shop with a Cop" held "Health disclosures by celebrities do matter, and we know this from decades of research across a lot of different health conditions and public figures," said Dr. Jessica Gall Myrick, a professor of health communication at Pennsylvania State University in University Park. "They absolutely do influence people." Some of the earliest celebrity health disclosures happened in the 1970s and 1980s with U.S. presidents and first ladies. When first lady Betty Ford was diagnosed with breast cancer just weeks after Gerald Ford became president in 1974, she spoke openly about her diagnosis, inviting photographers into the White House and helping make talk of cancer less taboo. In 1987, first lady Nancy Reagan used her breast cancer diagnosis as a chance to advocate for women to get mammograms. Her disclosure came two years after President Ronald Reagan's colon cancer diagnosis, about which the couple was equally as vocal. "Individuals throughout the country have been calling cancer physicians and information services in record numbers," the Los Angeles Times reported after Nancy Reagan's widely publicized surgery. The public showed a similar interest years earlier following Betty Ford's mastectomy. Another major milestone in celebrity health disclosures came in 1991, when 32-year-old NBA superstar Earvin "Magic" Johnson revealed he had tested positive for HIV, the virus that causes AIDS. "Life is going to go on for me, and I'm going to be a happy man," Johnson assured fans during a news conference. He immediately retired, only to return to the Los Angeles Lakers in 1996. His disclosure, along with his work as an advocate for safe sex, helped shatter stigmas around HIV and AIDS. Calls to testing centers increased significantly in the days and weeks after Johnson's announcement. "That celebrity disclosure really helped people see there was a wider susceptibly to HIV," Gall Myrick said. "People were more likely to say, 'I need to think about my own risks.' It was very powerful." When it comes to heart and stroke health, President Dwight Eisenhower helped make heart attacks less frightening and mysterious. During a news conference in 1955, millions of Americans learned from the president's doctors about his heart condition, his treatment, and concrete steps they could take to reduce their own heart attack risk. Other notable figures have shared their health experiences over the years. Soap opera legend Susan Lucci , who was diagnosed with heart disease in 2018, has advocated for women's heart health. Basketball great Kareem Abdul Jabbar talks about his irregular heartbeat, known as atrial fibrillation, and advocates for regular health screenings. Lawyer, author and television personality Star Jones continues to speak about heart disease risk after having lifesaving heart surgery in 2010. Longtime TV and radio personality Dick Clark brought stroke and aphasia into the national spotlight when he returned to hosting "New Year's Rockin' Eve" in Times Square just a year after his 2004 stroke and continued until his death in 2012. And actor and comedian Jamie Foxx recently revealed he had a stroke last year. "Celebrity disclosures represent teachable moments," said Dr. Seth M. Noar, director of the Communicating for Health Impact Lab at the University of North Carolina in Chapel Hill. "Searches for different health conditions often spike in the wake of these types of announcements. They cause people to think about these health issues, learn more about them, and in some cases change their behaviors." Celebrities have also highlighted the importance of CPR and the use of an automated external defibrillator, or AED, to restore a person's heartbeat if they experience cardiac arrest. Interest in CPR and AEDs spiked in 2023 after Buffalo Bills safety Damar Hamlin went into cardiac arrest during an NFL game broadcast on national TV. Views of the American Heart Association's hands-only CPR pages jumped more than 600% in the days following Hamlin's cardiac arrest. Three months later, around 3 million people had watched the AHA's CPR video. Family members of celebrities who have died from a heart issue have also spread awareness. After actor John Ritter died of an undiagnosed aortic dissection in 2003, his wife, actor Amy Yasbeck, started the Ritter Foundation to raise awareness about the condition and help others avoid a misdiagnosis. A literature review published in Systematic Reviews in 2017 found that people are conditioned to react positively to celebrity advice. Research also has found that people often follow advice from celebrities who match how they perceive – or how they want to perceive – themselves. The most effective celebrity disclosures are frequently the ones that tell a compelling story and include clear steps people can take to apply lessons the celebrity learned to their own health situation, Gall Myrick said. "People are more likely to take action when they feel confident and capable." Research has shown that celebrity disclosures often impact calls to hotlines and page views on health-related websites, and they can spark behavioral and even policy changes. Anecdotally, Gall Myrick said, people ask their doctor more questions about health conditions and request medical screenings. Celebrities can have a big impact because people tend to have parasocial relationships with them, Gall Myrick said. These are one-sided relationships in which a person feels an emotional connection with another person, often a celebrity. People may feel as if they know the basketball player they've watched on the court for years, or the Hollywood actor they've followed, she said. They want to comfort them after a health disclosure. Social media has only increased this feeling of familiarity, as celebrities regularly share mundane – but fascinating – details of their daily lives, like what they eat for breakfast, their favorite socks, or the meditation they do before bed. "We spend a lifetime being exposed to celebrities through the media, and over time, you get to know these public figures," Gall Myrick said. "Some feel like friendships." A study published in the journal Science Communication in 2020 compared reactions to actor Tom Hanks, who had COVID-19 early in the pandemic, and an average person with COVID-19. Researchers found that participants identified more with Hanks when it came to estimating their own susceptibility to COVID-19. The participants also felt more emotional about the virus that causes COVID-19 when thinking about it in relation to Hanks versus an average person. When a celebrity reveals a health condition, it's a surprise that may feel personal, especially if they are well-liked and the health issue is dramatic and sudden. "We feel like we know them, and the emotional response is what can then push people out of their routine," Gall Myrick said. Noar said a celebrity health story is often a more interesting and powerful way to learn about a health condition than just the facts, which can feel overwhelming. People are drawn to the slew of media coverage that typically follows a celebrity disclosure, he said. "Some of these high-visibility public figures' stories are now woven into some of these illnesses," Noar said. For example, Angelina Jolie is often linked to the BRCA1 gene mutation after the actor shared she had a preventive double mastectomy because of her elevated breast cancer risk and had her ovaries and fallopian tubes removed because of her increased risk for ovarian cancer. "It's a narrative, a story that humanizes the condition in a way that very informational communication really doesn't," Noar said. "People remember it, and it can potentially be a touch point." After a disclosure, patients may bring up a celebrity's story during a doctor's appointment and connect it to their own care. Today's multiplatform digital culture only amplifies celebrity messages. "You're seeing everyday people react to these events, and that can have a ripple effect too," Gall Myrick said. "We know from research that seeing messages more than once can be impactful. Often it's not just one billboard or one commercial that impacts behavior; it's the drip drip drip over time." Still, there's a cautionary tale to be told around the impact of celebrity health news, especially if the celebrity has died. An unclear cause of death may lead to speculation. Gall Myrick said that guesswork could potentially end up hurting rather than helping if patients were to act on misinformation or a lack of information. "Maybe the death was atypical or it needs more context," she said. "That's where advocacy groups and public health organizations come in. They need to be prepared for announcements or disclosures about celebrity deaths, and to fill in some of those gaps." American Heart Association News covers heart and brain health. Not all views expressed in this story reflect the official position of the American Heart Association. Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Sign up here to get the latest health & fitness updates in your inbox every week!Both head coaches regret negative impact transfer portal has on bowl games
Donald Trump in major TikTok ban move as he makes special request of Supreme CourtBig Ten After Dark is probably a suitable stage for the 5-5 Trojans and 4-6 Bruins on Saturday night from the Rose Bowl
In wake of officer's death, West Yellowstone police offer aid for those grievingSAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Symbotic Inc. (NASDAQ: SYM) securities between February 8, 2024 and November 26, 2024. Symbotic is an automation technology company that engages in the production of a robotics and automation-based product movement technology platform. For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Symbotic Inc. (SYM) Failed to Disclose Material Weaknesses in its Internal Control Over Financial Reporting According to the complaint, on November 27, 2024, the Company filed with the SEC a Form 8-K/A, in which the Company revealed it had "identified errors in its revenue recognition related to cost overruns on certain deployments that will not be billable, which additionally impacted system revenue, income (loss) before income tax, net income (loss) and gross margin recognized in the second, third, and fourth quarters of fiscal year 2024." Further, the Company indicated that its previously issued financial statements for the fourth quarter and fiscal year 2024 and the Company’s supplemental presentation, should no longer be relied upon. On this news, the price of Symbotic stock fell over 35%, to close at $24 per share on November 27, 2024. What Now : You may be eligible to participate in the class action against Symbotic Inc. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by February 3, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP : Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Symbotic Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3edbf291-c5a4-45f0-a769-259266b2c15b